American International Group’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,424
| Closed | -$37.5K | – | 1585 |
|
|
2024
Q1 | $37.5K | Buy |
2,424
+6
| +0.2% | +$129 | ﹤0.01% | 2842 |
|
|
2023
Q4 | $67.7K | Sell |
2,418
-9
| -0.4% | -$236 | ﹤0.01% | 2735 |
|
|
2023
Q3 | $116K | Buy |
2,427
+86
| +4% | +$6.56K | ﹤0.01% | 2429 |
|
|
2023
Q2 | $224K | Buy |
2,341
+641
| +38% | +$69.8K | ﹤0.01% | 2096 |
|
|
2023
Q1 | $193K | Buy |
1,700
+33
| +2% | +$3.57K | ﹤0.01% | 2126 |
|
|
2022
Q4 | $187K | Sell |
1,667
-6
| -0.4% | -$804 | ﹤0.01% | 2163 |
|
|
2022
Q3 | $215K | Buy |
1,673
+24
| +1% | +$2.46K | ﹤0.01% | 2114 |
|
|
2022
Q2 | $113K | Sell |
1,649
-79
| -5% | -$6.81K | ﹤0.01% | 2529 |
|
|
2022
Q1 | $246K | Sell |
1,728
-121
| -7% | -$18.6K | ﹤0.01% | 2116 |
|
|
2021
Q4 | $308K | Sell |
1,849
-56
| -3% | -$8.9K | ﹤0.01% | 2099 |
|
|
2021
Q3 | $265K | Sell |
1,905
-45
| -2% | -$8.8K | ﹤0.01% | 2255 |
|
|
2021
Q2 | $930 | Buy |
1,950
+340
| +21% | +$143K | ﹤0.01% | 1558 |
|
|
2021
Q1 | $663 | Buy |
1,610
+5
| +0.3% | +$2.3K | ﹤0.01% | 1687 |
|
|
2020
Q4 | $787 | Buy |
1,605
+18
| +1% | +$10.5K | ﹤0.01% | 1522 |
|
|
2020
Q3 | $899K | Buy |
1,587
+243
| +18% | +$80.8K | ﹤0.01% | 1306 |
|
|
2020
Q2 | $128K | Buy |
1,344
+264
| +24% | +$23.2K | ﹤0.01% | 2371 |
|
|
2020
Q1 | $77K | Sell |
1,080
-62
| -5% | -$4.16K | ﹤0.01% | 2467 |
|
|
2019
Q4 | $79K | Sell |
1,142
-10
| -0.9% | -$742 | ﹤0.01% | 2738 |
|
|
2019
Q3 | $92K | Buy |
1,152
+470
| +69% | +$31.1K | ﹤0.01% | 2659 |
|
|
2019
Q2 | $44K | Buy |
682
+25
| +4% | +$2.37K | ﹤0.01% | 2972 |
|
|
2019
Q1 | $90K | Sell |
657
-21
| -3% | -$2.56K | ﹤0.01% | 2668 |
|
|
2018
Q4 | $61K | Sell |
678
-5
| -0.7% | -$700 | ﹤0.01% | 2816 |
|
|
2018
Q3 | $104K | Buy |
683
+12
| +2% | +$1.94K | ﹤0.01% | 2818 |
|
|
2018
Q2 | $115K | Buy |
671
+17
| +3% | +$2.78K | ﹤0.01% | 2703 |
|
|
2018
Q1 | $96K | Sell |
654
-35
| -5% | -$6.71K | ﹤0.01% | 2675 |
|
|
2017
Q4 | $140K | Buy |
689
+3
| +0.4% | +$616 | ﹤0.01% | 2539 |
|
|
2017
Q3 | $220K | Buy |
686
+52
| +8% | +$14.2K | ﹤0.01% | 2243 |
|
|
2017
Q2 | $143K | Buy |
634
+85
| +15% | +$17.5K | ﹤0.01% | 2486 |
|
|
2017
Q1 | $124K | Buy |
549
+36
| +7% | +$7.31K | ﹤0.01% | 2470 |
|
|
2016
Q4 | $101K | Sell |
513
-1
| -0.2% | -$218 | ﹤0.01% | 2601 |
|
|
2016
Q3 | $126K | Buy |
514
+1
| +0.2% | +$351 | ﹤0.01% | 2468 |
|
|
2016
Q2 | $298K | Buy |
513
+264
| +106% | +$155K | ﹤0.01% | 1880 |
|
|
2016
Q1 | $132K | Buy |
+249
| New | +$130K | ﹤0.01% | 3164 |
|
Other funds holding MCRB
FP
TCM
American International Group's MCRB Position: Q2 2024 in Review
American International Group sold out of Seres Therapeutics (MCRB) in Q2 2024, closing a stake of 2,424 shares — an estimated $37.5K sold.
American International Group first reported a position in MCRB in Q1 2016 and held it in 33 quarters. The position peaked at $899K in Q3 2020. 93 funds tracked by Wall St. Rank hold MCRB as of Q2 2024.
- American International Group reported no remaining Seres Therapeutics position as of Q2 2024 after selling out during the quarter.
- American International Group sold 2,424 Seres Therapeutics shares in Q2 2024, an estimated $37.5K.
- American International Group first reported a position in Seres Therapeutics in Q1 2016 and held it in 33 quarters.
- American International Group's Seres Therapeutics position peaked at $899K in Q3 2020.
- 93 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.